LOUISE WILSON: Open Payments
NPI 1326276874 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,234 in 128 payments from 14 companies in 2025. Trend: 2023 $2,529 · 2024 $2,986 · 2025 $2,234
Food & beverage: $2,234
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $436 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 28 | $387 |
| Aimmune Therapeutics, Inc. | 20 | $270 |
| PFIZER INC. | 16 | $210 |
| Celltrion USA Inc. | 12 | $197 |
| ABBVIE INC. | 9 | $179 |
| Phathom Pharmaceuticals, Inc. | 3 | $159 |
| Janssen Scientific Affairs, LLC | 1 | $151 |
| GENZYME CORPORATION | 2 | $63 |
| Exact Sciences Corporation | 2 | $58 |
Products named: TREMFYA, XIFAXAN, ZENPEP, VELSIPITY, VEGZELMA, VOQUEZNA, DUPIXENT, RINVOQ.
Industry payments across TX — which companies pay providers there.
